FIELD: pharmacology.
SUBSTANCE: one should apply glycosaminoglycanes at average molecular weight being 2400 D to prepare pharmaceutical composition for treating senile feeble-mindedness and neurological cerebral lesions induced due to sudden attack or trauma. The innovation suggested increases the number of medicinal preparations of necessary indication.
EFFECT: higher efficiency of application.
7 cl, 2 dwg, 8 tbl
Title | Year | Author | Number |
---|---|---|---|
GLYCOSAMINOGLYCANS FOR EMOTIONAL INSANITY TREATMENT | 2004 |
|
RU2353371C2 |
BAKERY AND PASTA CONTAINING ACIDIFIED CHITOSAN | 2006 |
|
RU2404685C2 |
NON-ANTICOAGULANT GLYCOSAMINOGLYCANS WITH REPEATING DISACCHARIDE UNITS, AND THEIR MEDICAL APPLICATION | 2012 |
|
RU2617764C2 |
CHINESE MEDICINAL COMPOSITION, METHOD FOR PREPARING AND ADMINISTRATION | 2006 |
|
RU2408384C2 |
EXOGENIC-INDUCED ANIMAL MODEL OF ALZHEIMER DISEASE | 2012 |
|
RU2532525C2 |
USING ANTI-AMYLOID BETA ANTIBODY IN OPHTHALMIC DISEASES | 2008 |
|
RU2604181C2 |
DIPHENYLALKYLTETRAHYDROPYRIDINES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF | 1997 |
|
RU2198874C2 |
AGENT ENHANCING ANTI-INFLAMMATORY EFFECT OF IMMUNODEPRESSANT (VERSIONS), METHOD OF ENHANCEMENT OF ANTI-INFLAMMATORY EFFECT OF IMMUNODEPRESSANT, METHOD OF INFLAMMATION TREATMENT | 1996 |
|
RU2176509C2 |
1-PHENYLALKYL-1,2,3,6-TETRAHYDROPYRIDINES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2189975C2 |
METHOD OF USE IN THERAPY | 2010 |
|
RU2579659C2 |
Authors
Dates
2005-03-27—Published
2000-05-12—Filed